IPVC 2020 Free Live Webinar Series – Register now
To thank the IPVC 2020 participants, faculty, speakers and much of the global HPV community for making the conference a success – IPVS is pleased to offer a series of three one-hour LIVE webinar sessions over the coming weeks to continue in the vein of Science & Education for Action Against HPV. These sessions are FREE of […]
IPVC 2020 Free Live Webinars – Session II: HPV DNA Testing
IPVS is pleased to offer a series of three one-hour LIVE webinar sessions over the coming weeks to continue in the vein of Science & Education for Action Against HPV. These sessions are FREE of charge and open to all who are interested. Session II – 3 Dec 2020 13:00-14:00 CET Current issues for HPV testing […]
IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa
IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa Monday, 24th January 2022 12:00-13:30 EST (New York) / 18:00-19:30 CET (Geneva) Topic: Sub Saharan Africa (SSA) has a very high burden of cervical cancer. HPV vaccines are being introduced in many countries in the region but there are many challenges in implementation for the adolescent […]
IPVC 2020 Free Live Webinars – Session III: Cervical Cancer Elimination – Now, Later or Never
IPVS is pleased to conclude the Post-IPVC 2020 series of free one-hour LIVE webinars in Science & Education for Action Against HPV with the following timely topic: Elimination of Cervical Cancer: Now, Later or Never Session III – 17 Dec 2020 13:00-14:00 CET Speaker: Prof. J. Dillner MD, PhD, Prof of infectious disease epidemiology, […]
IPVS webinar: HPV pathobiology – lessons learned from mice
IPVS webinar: HPV pathobiology – lessons learned from mice Wednesday, 23rd February 2022 10:00 EST (New York) / 16:00 CET (Geneva) Moderator: Neil Christensen Professor Penn State University, College of Medicine Speakers: Megan Spurgeon Ph.D. University of Wisconsin School of Medicine and Public Health Richard Roden Professor Johns Hopkins University Topic: During this webinar, […]
IPVS Educational Webinar Series 2021 – Session I: HPV Latency
IPVS is pleased to begin our Educational Webinar Series for 2021 with Session I: HPV Latency: Is it real and does it Matter? 17 February 2021 17:00-18:00 CET Speakers: Dr. Anna-Barbara Moscicki, Professor of Pediatrics, University of California, Los Angeles Prof. John Doorbar, Division of Virology, Department of Pathology, University of Cambridge, UK. Moderator: Prof. […]
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses Wednesday, 23rd March 2022 12:00-13:00 EDT (New York) / 17:00-18:00 CET (Geneva) Topic: Have you missed the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses or would you like to learn more about HPV antiviral drugs? Join […]
European Cancer Organization: Eliminating HPV Cancers in Europe – Next Steps
25 February 2021 14:30-16:30 CET Europe’s new Beating Cancer Plan provides the launchpad for a new effort to eliminate all the cancers caused by HPV across the EU and the wider European region. The European Cancer Organisation’s HPV Action Network is hosting a webinar for the members and stakeholders to discuss how ECO member organisations, […]
IPVS webinar: Everything you need to know about HPV and pregnancy
IPVS webinar: Everything you need to know about HPV and pregnancy Thursday, 28th April 2022 12:00-13:30 EDT (New York) / 18:00-19:30 CEST (Geneva) Topic: Join our upcoming webinar to learn everything you need to know about HPV and pregnancy. HPV lesion treatment is known to be associated with obstetrical complications and now HPV infection in […]
IPVS Educational Webinar Series 2021 – The Future of HPV Research
IPVS is pleased to announce the following session of our Educational Webinar Series for 2021 Session II: The Future of HPV Research: Capitalizing on Current Opportunities 22 April 2021 17:00-18:00 CET (Geneva)/ 08:00-09:00 PST (Los Angeles) Moderator: Dr. Elisabeth McClymont, PhD, University of Montreal, Department of Obstetrics & Gynecology Topic: The aim of this session […]
